The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques

Abstract Purpose The aim of this study was to evaluate the impact of18 F-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) on clinical management in patients with locoregional breast cancer recurrence amenable for locoregional treatment and to compare the PET/CT result...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2010-04, Vol.36 (4), p.387-392
Hauptverfasser: Aukema, T.S, Rutgers, E.J.Th, Vogel, W.V, Teertstra, H.J, Oldenburg, H.S, Vrancken Peeters, M.T.F.D, Wesseling, J, Russell, N.S, Valdés Olmos, R.A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Purpose The aim of this study was to evaluate the impact of18 F-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) on clinical management in patients with locoregional breast cancer recurrence amenable for locoregional treatment and to compare the PET/CT results with the conventional imaging data. Patients and methods From January 2006 to August 2008, all patients with locoregional breast cancer recurrence underwent whole-body PET/CT. PET/CT findings were compared with results of the conventional imaging techniques and final pathology. The impact of PET/CT results on clinical management was evaluated based on clinical decisions obtained from patient files. Results 56 patients were included. In 32 patients (57%) PET/CT revealed additional tumour localisations. Distant metastases were detected in 11 patients on conventional imaging and in 23 patients on PET/CT images ( p  
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2009.11.009